[D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Pharmacology

• Publication date

  1996-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0014-2999(96)00221-XPMID 8813628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

  1995cited by this paper
• The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

  1995cited by this paper
• Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

  1995cited by this paper
• A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.

  1995cited by this paper
• Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs.

  1994cited by this paper
• Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.

  1993cited by this paper
• Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

  1993cited by this paper
• Relaxing actions of corticotropin‐releasing factor on rat resistance arteries

  1993cited by this paper
• Expression cloning of a human corticotropin-releasing-factor receptor.

  1993cited by this paper
• Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics.

  1993cited by this paper
• Anti-inflammatory peptide agonists.

  1993cited by this paper
• Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.

  1992cited by this paper
• Physiology and pharmacology of corticotropin-releasing factor.

  1991cited by this paper
• Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin.

  1989cited by this paper
• Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin.

  1988cited by this paper
• Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat.

  1984cited by this paper
• In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.

  1983cited by this paper
• Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.

  1983cited by this paper
• Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.

  1982cited by this paper
• Sauvagine, a new polypeptide from Phyllomedusa sauvagei skin

  1980cited by this paper
• Nonparametric statistics for the behavioral sciences

  1956cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Key role of CRF in the skin stress response system.

  2013cites this paper
• Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.

  2001cites this paper
• GABA and chloride permeate via the same channels across single plasma membranes microdissected from rabbit Deiters' vestibular neurones.

  2001cites this paper
• Multiple functions of polypeptides mediated by distinct domains interacting with different receptors.

  1999cites this paper
• Bipolar-shape response of human neutrophils to corticotropin-releasing factor.

  1998cites this paper
• D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.

  1998cites this paper
• Analogues anti-inflammatoires de crf, leur composition et leur emploi

  1997cites this paper